Not sure if this is a pattern but my experience has been the same across multiple companies.
I've only ever received responses from the CEO. Both messages addressed to 'investor relations" were completely ignored.
- Forums
- ASX - By Stock
- IHL
- Ann: IHL-675A outperforms existing treatment for arthritis
Ann: IHL-675A outperforms existing treatment for arthritis, page-178
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)